GlassScriptPhysician profile
Larisa B Elberg
NPI 1295782209
$1,000.41
in general payments reported to CMS, 2019-2025
16 companies · $78.68 in 2025
The $78.68 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $155 · 2021: $186 · 2022: $123 · 2023: $64.32 · 2024: $218 · 2025: $78.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $509.69 | 2021-2025 | |
| Ucb, INC. | $137.31 | 2020-2021 | |
| Adamas Pharmaceuticals, INC. | $56.02 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $54.37 | 2019 | |
| Scilex Pharmaceuticals INC. | $33.43 | 2020 | |
| Ge Healthcare | $30.73 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $21.82 | 2020 | |
| Horizon Therapeutics Plc | $21.59 | 2021 | |
| Livanova USA, INC. | $21.05 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.40 | 2020 | |
| Pfizer INC. | $18.12 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.13 | 2022 | |
| Sk Life Science, INC. | $14.25 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larisa Elberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.